LXEO compared with AURA: revenue, margins and what each company keeps, and the suppliers and customers both name

LXEOLexeo Therapeutics, Inc.

Mkt capRevenueRevenue

AURAAura Biosciences, Inc.

Mkt capRevenueRevenue

Compare

LXEOLexeo Therapeutics, Inc.

AURAAura Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LXEO

0 of 3at or beyond implied

Reportimpliedrealized× implied

Aug 12 '26±70.2%▲+1.88%×0.03

May 11 '26±60.6%▲+4.97%×0.08

Mar 31 '26—▲+8.92%—

Nov 5 '25±15.7%▼−1.80%×0.11

AURA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 11 '26±83.3%▲+4.42%×0.05

May 12 '26±49.3%▼−3.17%×0.06

= impliedLXEO realized, solidAURA realized, hatchedOne scale, both sides: full bar = 84%× = |realized| ÷ impliedspan: LXEO 280d · AURA 134dSource: market data

May 5 '26

±44.7%

▲+6.59%

×0.15

Mar 30 '26±64.1%▼−1.12%×0.02

LXEOLexeo Therapeutics, Inc.

3.14▲+2.61%· post 3.14

Mkt cap$257.6M

AURAAura Biosciences, Inc.

6.14▼−2.46%· post 6.14

ClosedOct 30 '26

Mkt cap$636.7M

Compare

ClosedOct 30 '26

LXEOLexeo Therapeutics, Inc.

AURAAura Biosciences, Inc.

3.14▲+2.61%post 3.14

Price

6.14▼−2.46%post 6.14

$257.6M

Mkt cap

$636.7M

LXEO3.14▲+2.61%vsAURA6.14▼−2.46%ClosedOct 30 '26